Company Profile
Nuformix Technologies Limited
06407331•Private Limited With Share Capital
Get Full Access
23/10/2007
18 years
3
3
72110
high risk
Company Overview
Registration, classification & business activity
Nuformix Technologies Limited (06407331) is a private limited with share capital incorporated on 23/10/2007 (18 years old) and registered in london, EC2N4BQ. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Unlocking the potential of therapeutics for fibrosis & oncologynuformix is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing. the company aims to use its expertise in discovering, developing and patenting novel drug forms, with improved ...
Financial Overview
£65.3K
£3.86M
£-3.80M
£2.54M
£57.3K
Key Metrics
3
Employees
3
Directors
1
Shareholders
1
CCJs
Board of Directors
Innovate Grants
This company received a grant of £43814.0 for Cocrystal-Enabled Inhaled Therapy For Idiopathic Pulmonary Fibrosis. The project started on 01/06/2015 and ended on 31/03/2016.
Risk Assessment
high risk
International Score
Future Factor
emerging
Performance Rating